- Home
- » Tags
- » Emtricitabine
Top View
- Drugs That Fight
- Antiviral Drugs in the Treatment of Aids: What Is in the Pipeline ?
- Efavirenz/Emtricitabine/Tenofovir Disoproxil Fumarate) Initiating Treatment with ATRIPLA and Periodically During Tablets, for Oral Use Treatment
- Common Study Protocol for Observational Database Studies WP5 – Analytic Database Studies
- Total Synthesis of Thia-Calanolide a and Analogues, Asymmetric Aziridination of Alkenes and Development of Environmentally Benign Green Methodologies
- EFAVIRENZ/ EMTRICITABINE/ TENOFOVIR (Atripla
- TABLE 2. HIV Treatment Pipeline 2003–2012 Class Drug Name Generic Name Brand Name Sponsor 2003 2004 2005 2006 2007 2008 2009 2
- Efavirenz, Emtricitabine, and Tenofovir Disoproxil Fumarate
- Drug Resistance of Human Immunodeficiency Virus and Overcoming It by Natural Products
- GLASS Methodology for Surveillance of National Antimicrobial Consumption
- Risk Management Plan Emtricitabine/Tenofovir Disoproxil RMP Version 3.0
- Metabolic and Body Composition Effects of Newer Antiretrovirals in HIV-Infected Patients
- EMTRIVA® (Emtricitabine) Capsule, for Oral Use 200 Mg 200 Mg 200 Mg EMTRIVA® (Emtricitabine) Oral Solution Capsule 200 Mg Every Every Every Initial U.S
- Annex I Summary of Product Characteristics
- Emtricitabine / Tenofovir Disoproxil) an Overview of Emtricitabine/Tenofovir Disoproxil Mylan and Why It Is Authorised in the EU
- Labeled Maraviroc
- Switching to Fixed-Dose Bictegravir, Emtricitabine, and Tenofovir Alafenamide from Dolutegravir Plus Abacavir and Lamivudine In
- Emtricitabine/Tenofovir Disoproxil, Film Coated Tablet
- Recreational Drugs and HIV Antiretrovirals a Guide to Interactions for Clinicians
- Application for Listing of Atazanavir for the Treatment of Hiv-1 Infection on the Who Model List of Essential Medicines
- Parenteral Inhibitors of HIV Entry in Current Development The
- ATRIPLA Safely and Effectively
- Efavirenz/Emtricitabine/Tenofovir Disoproxil Mylan, INN-Efavirenz
- HIV Antiretroviral Medication Coding Chart for ARIES Input
- HIV-1 Entry, Inhibitors, and Resistance
- EMTRIVA (Emtricitabine) Capsule, for Oral Use Sisa ® EMTRIVA (Emtricitabine) Oral Solution 200 Mg Capsule 200 Mg Every 200 Mg Every 200 Mg Every Every 96 Initial U.S
- Guidance for Non-HIV-Specialized Providers Caring for Persons with HIV Who Have Been Displaced by Disasters (Such As a Hurricane)
- Tenofovir Disoproxil Emtricitabine Efavirenz Mylan
- Descovy, INN-Emtricitabine / Tenofovir Alafenamide
- Truvada (Emtricitabine Tenofovir Disoproxil
- How to Choose a PEP Regimen?
- Comparison of Abacavir/Lamivudine and Tenofovir/ Emtricitabine Among Treatment-Naive HIV-Infected Patients Initiating Therapy
- Emtricitabine/Tenofovir Alafenamide (Descovy®) EOCCO POLICY Policy Type: PA/SP Pharmacy Coverage Policy: EOCCO188
- PRESCRIBING INFORMATION Lamivudine 150Mg/Zidovudine 300
- Atazanavir (Reyataz)
- Efavirenz, Emtricitabine, and Tenofovir Disoproxil Fumarate: Pediatric
- MEDICATION GUIDE Lamivudine and Tenofovir Disoproxil Fumarate Tablets, 300 Mg/300 Mg Co-Packaged with Nevirapine Tablets USP, 200 Mg
- TRUVADA® (Emtricitabine/Tenofovir Disoproxil
- Antivirals : HIV – Emtricitabine / Tenofovir Alafenamide (Descovy®) Medical Policy No
- Information on Crushing and Liquid Drug Formulations
- Mitochondrial Toxicity of Tenofovir, Emtricitabine and Abacavir Alone and in Combination with Additional Nucleoside Reverse Transcriptase Inhibitors
- Recent Developments in HIV Treatment and Their Dissemination in Poor
- Pharmacological Equivalence and Clinical Interchangeability of Lamivudine and Emtricitabine: a Review of Current Literature
- Truvada® (Emtricitabine-Tenofovir Disoproxil Fumarate) Viread® (Tenofovir Disoproxil Fumarate) Emtriva® (Emtricitabine) BENEFIT APPLICATION
- Truvada Medication Information Sheet for Patients
- REYATAZ (Atazanavir)
- Emtriva (Emtricitabine)
- Emtricitabine and Tenofovir Disoproxil Fumarate
- Post-Catalytic Complexes with Emtricitabine Or Stavudine and HIV
- Zidovudine-Lamivudine (Combivir)
- Emtricitabine
- Emtriva, INN-Emtricitabine
- ARV-ARV Drug Combinations to Be Avoided (DUR POS Edits)
- Cost-Effectiveness Analysis of Tenofovir/Emtricitabine and Abacavir/Lamivudine in Combination with Efavirenz Or Atazanavir/Rito
- Information for the User Emtricitabine/Tenofovir Disoproxil
- Truvada, INN-Emtricitabine / Tenofovir Disoproxil
- Risk Management Plan Emtricitabine/Tenofovir (As Phosphate) V1.1
- Page: Treatment-Drugs
- Safety and Effectiveness of Tenofovir/Emtricitabine Or
- ESAC-Net Reporting Protocol 2018.Docx Introduction
- Atazanavir/Cobicistat
- CONCLUSION and RELEVANCE the Analysis of Prescriptions in the Period 2016-2019 Showed a Decrease in TDF-Based Therapies in Favor of TAF-Based Prescribing Regimens